TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Recipharm AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
63,585
|
53,506
|
24,237 |
| Financial expenses |
588,500
|
308,075
|
160,143 |
| Earnings before taxes |
-793,989
|
-1,895
|
7,706 |
| EBITDA |
-27,622
|
-15,852
|
-24,311 |
| Total assets |
2,068,057
|
2,651,743
|
1,698,287 |
| Current assets |
1,173,126
|
357,185
|
244,110 |
| Current liabilities |
396,490
|
190,008
|
162,613 |
| Equity capital |
825,812
|
1,616,087
|
690,999 |
| - share capital |
4,556
|
4,543
|
4,944 |
| Employees (average) |
60
|
67
|
64 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.9%
|
60.9%
|
40.7% |
| Turnover per employee |
1,060
|
799
|
379 |
| Profit as a percentage of turnover |
-1248.7%
|
-3.5%
|
31.8% |
| Return on assets (ROA) |
-9.9%
|
11.5%
|
9.9% |
| Current ratio |
295.9%
|
188.0%
|
150.1% |
| Return on equity (ROE) |
-96.1%
|
-0.1%
|
1.1% |
| Change turnover |
9,923
|
31,232
|
-1,058,065 |
| Change turnover % |
18%
|
140% | |
| Chg. No. of employees |
-7
|
3
|
-7,793 |
| Chg. No. of employees % |
-10%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.